Association between PON 1 polymorphisms, PON activity and diabetes complications.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of diabetes and its complications

• Publication date

  2006-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JDIACOMP.2005.08.008PMID 16949520
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polymorphisms in the human paraoxonase (PON1) promoter.

  2001cited by this paper
• Paraoxonase and Atherosclerosis

  2001cited by this paper
• Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation.

  2001cited by this paper
• The paraoxonase PON1 promoter polymorphism C(-107)T is associated with increased serum glucose concentrations in non-diabetic patients

  2001cited by this paper
• Paraoxonase promoter polymorphism T(–107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease

  2001cited by this paper
• Paraoxonase producing PON1 gene M/L55 polymorphism is related to autopsy-verified artery-wall atherosclerosis.

  2001cited by this paper
• Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus.

  2001cited by this paper
• Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.

  2001cited by this paper
• Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.

  2000cited by this paper
• Polymorphisms of human paraoxonase 1 gene (PON1) and susceptibility to diabetic nephropathy in Type I diabetes mellitus

  2000cited by this paper
• Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations.

  2000cited by this paper
• A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression.

  2000cited by this paper
• Paraoxonase (PON1) Phenotype Is a Better Predictor of Vascular Disease Than Is PON1192 or PON155 Genotype

  2000cited by this paper
• Diabetes Complication Screening in 937 Children and Adolescents

  1999cited by this paper
• Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidation.

  1999cited by this paper
• Low serum paraoxonase: a risk factor for atherosclerotic disease?

  1999cited by this paper
• Dichlorophenyl phosphoramidates as substrates for avian and mammalian liver phosphotriesterases: activity levels, calcium dependence and stereospecificity.

  1999cited by this paper
• Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

  1998cited by this paper
• Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus.

  1998cited by this paper
• Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study.

  1998cited by this paper
• Lipid profiles and blood pressure: are they risk factors for the development of early background retinopathy and incipient nephropathy in children with insulin‐dependent diabetes mellitus?

  1996cited by this paper
• The Diabetes Control and Complications Trial: Implications for children and adolescents

  1995cited by this paper
• The Diabetes Control and Complications Trial. Implications for children and adolescents. Australasian Paediatric Endocrine Group.

  1995cited by this paper
• Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins.

  1995influential reference
• Toxicity of Mildly Modified Low-Density Lipoproteins to Cultured Retinal Capillary Endothelial Cells and Pericytes

  1994cited by this paper
• Prevalence and risk factors for retinopathy in adolescents with type 1 diabetes

  1994cited by this paper
• The molecular basis of the human serum paraoxonase activity polymorphism

  1993cited by this paper
• Diabetes Control and Complications Trial

  1993cited by this paper
• Pupillary Abnormalities in Type I Diabetes Occurring During Adolescence: Comparisons with cardiovascular reflexes

  1993cited by this paper
• Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus.

  1991cited by this paper
• Acta Paediatrica Scandinavica

  1991cited by this paper
• Microalbuminuria in adolescents with insulin-dependent diabetes mellitus.

  1990cited by this paper
• The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years.

  1989cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper
• The Prevalence of Microalbuminuria in Diabetic Children and Adolescents and Its Relation to Puberty

  1987cited by this paper
• The Wisconsin Epidemiologic Study of Diabetic Retinopathy. VI. Retinal photocoagulation.

  1987cited by this paper
• Prevalence of microalbuminuria in children with Type 1 (insulin-dependent) diabetes mellitus

  1986cited by this paper

• Investigation of paraoxonase1 enzyme activity and Q/R 192 polymorphism in severe COVID-19 cases

  2025cites this paper
• Talinum triangulare (Jacq.) Willd: A review of its traditional uses, phytochemistry, and pharmacology along with network pharmacology analysis of its components and targets

  2024cites this paper
• The importance of paraoxonase 1 activity in chronic kidney disease

  2024cites this paper
• The Incidence of the XRCC1 rs25487 and PON1 rs662 Polymorphisms in a Population from Central Brazil: Patterns in an Area with a High Level of Agricultural Activity

  2023cites this paper
• Association between PON1-rs662 Gene Polymorphism and Diabetic Retinopathy in Population of the Qom, Iran

  2023cites this paper
• Alelos -108C/T, L55M y Q192R de paraoxoasa 1 (pon 1) en población del eje cafetero de Colombia

  2023cites this paper
• The Effect of Oxidative Stress and Antioxidant Capacity on Postmenopausal Bone Mineral Densitometry

  2022influential citation
• The Relationship between Cancer and Paraoxonase 1

  2022cites this paper
• Paraoxonase 1 (PON1) L55M and Q192R polymorphisms are not associated with chronic kidney disease in Thai individuals with type 2 diabetes

  2021cites this paper
• The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases

  2021cites this paper
• MALDI-TOF Protein Profiling Reflects Changes in Type 1 Diabetes Patients Depending on the Increased Amount of Adipose Tissue, Poor Control of Diabetes and the Presence of Chronic Complications

  2021cites this paper
• Importance of paraoxonase 1 (PON1) as an antioxidant and antiatherogenic enzyme in the cardiovascular complications of type 2 diabetes: Genotypic and phenotypic evaluation.

  2020cites this paper
• Cholesterol Myth and the Imperative Role of Functional Evaluation of Lipoproteins in Atherosclerotic Risk Prediction Strategies

  2019cites this paper
• Correlation Between Serum PON1 Arylesterase Activity and Rs 854573 PON1 A < G Polymorphism with Type 2 Diabetes in an Eastern Indian Cohort

  2019cites this paper
• Paraoxonase 1 (PON1)-L55M among common variants in the coding region of the paraoxonase gene family may contribute to the glycemic control in type 2 diabetes.

  2018cites this paper
• PON1 promoter polymorphisms contribute to PCOS susceptibility and phenotypic outcomes in Indian women.

  2018cites this paper
• The Associations between Paraoxonase 1 L55M/Q192R Genetic Polymorphisms and the Susceptibilities of Diabetic Macroangiopathy and Diabetic Microangiopathy: A Meta-Analysis

  2018cites this paper
• Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetes

  2018cites this paper
• Paraoxonase 1 activities and its gene promoter single nucleotide polymorphisms (-108, -126, and -162) in diabetes mellitus

  2018cites this paper
• Serum Antioxidative Enzymes Levels and Oxidative Stress Products in Children and Adolescents with Type I Diabetes Mellitus

  2018cites this paper
• THE CARDIO - PROTECTIVE "PARAOXONASE - 1" AS A VALUABLE PROMISING TOOL IN DIAGNOSIS AND/OR ASSESSMENT OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES

  2018cites this paper
• Evaluation of Association Between Q192R and L55M Genetic Polymorphisms of PON1 and Serum Paraoxonase-1 Activity in Healthy Individuals, a Meta-Analysis

  2018cites this paper
• Possible Effects of Paraoxonase 1 Q192r Polymorphism on Serum Paraoxonase Activities of a Group of Type 2 Diabetes Mellitus Patients

  2017cites this paper
• Paraoxonase 1 (PON1) and stroke; the dilemma of genetic variation.

  2017influential citation
• The serum protein responses to treatment with Xiaoke Pill and Glibenclamide in type 2 diabetes patients

  2017cites this paper
• A study of paraoxonase1 (PON1) activities, HDL cholesterol and its association with vascular complication in type 2 diabetes mellitus

  2016cites this paper
• DIABETIC STUDIES The Review of Biomarkers in Diabetic Retinopathy

  2016cites this paper
• Bovine Paraoxonase-1 Activity in Oxidative Stress

  2016cites this paper
• Is there a relation between genetic susceptibility with cancer? A study about paraoxanase (PON1) enzyme activity in breast cancer cases

  2016cites this paper
• Effect of paraoxonase 1 192 Q/R polymorphism on paraoxonase and acetylcholinesterase enzyme activities in a Turkish population exposed to organophosphate

  2015cites this paper
• Antioxidant properties of HDL

  2015cites this paper
• How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae

  2015cites this paper
• Biomarkers in Diabetic Retinopathy.

  2015cites this paper
• Desenvolvimento de novas ferramentas analíticas para a monitorização da actividade da Paraoxonase 1 em amostras de plasma humano

  2015cites this paper
• Paraoxonase 1 polymorphisms (L55M and Q192R) as a genetic marker of diabetic nephropathy in youth with type 1 diabetes.

  2015cites this paper
• Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?

  2014cites this paper
• The influence of gene polymorphisms, modifiable lifestyle factors, and toxicants on the protective effects of the paraoxonase genes

  2014cites this paper
• Current Trends in the Monitoring and Treatment of Diabetic Retinopathy in Young Adults

  2014cites this paper
• PEP-1-PON1 Protein Regulates Inflammatory Response in Raw 264.7 Macrophages and Ameliorates Inflammation in a TPA-Induced Animal Model

  2014cites this paper
• High-density lipoprotein impedes glycation of low-density lipoprotein

  2013cites this paper
• Association between paraoxonase gene and stroke in the Han Chinese population

  2013cites this paper
• Relationship of PON1 activity and hsCRP concentration with disease status in patients with type 2 diabetes mellitus with and without retinopathy

  2013cites this paper
• Paraoxonase 1, atherosclerosis and arterial stiffness in renal patients

  2013cites this paper
• Évaluation de polymorphismes de p22phox, RAGE et ALOX12 dans la survenue de la néphropathie diabétique chez le type 1 : projet NEPHRODIANOX

  2013cites this paper
• Pharmacogenetics in Drug Metabolism: Role of Phase I Enzymes

  2012cites this paper
• HDL functionality

  2012cites this paper
• Epidemiology, risk factors and management of paediatric diabetic retinopathy

  2012cites this paper
• Are PON1 Q/R 192 and M/L 55 polymorphisms risk factors for diabetes complications in Turkish population?

  2011cites this paper
• Diminished Antioxidant Activity of High-Density Lipoprotein–Associated Proteins in Systolic Heart Failure

  2011cites this paper
• The three-gene paraoxonase family: physiologic roles, actions and regulation.

  2011cites this paper
• Biomarkers for Diabetes Complications: The Results of Several Clinical Studies

  2011cites this paper
• Increased levels of total oxidant status and decreased activity of arylesterase in migraineurs.

  2011influential citation
• Q192R polymorphism of the paraoxonase-1 gene as a risk factor for obesity in Portuguese women.

  2011cites this paper
• The relationship of PON1 QR 192 and LM 55 polymorphisms with serum paraoxonase activities of Turkish diabetic patients

  2011cites this paper
• Human PON promoters: from similarity to prediction of polymorphic positions within transcription factor elements.

  2010cites this paper
• Paraoxonase 1 activity as a predictor of cardiovascular disease in type 2 diabetes.

  2010cites this paper
• patient-oriented and epidemiological research Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes

  2009cites this paper
• Early predictors of microvascular complications in type 1 diabetic patients.

  2009cites this paper
• Evaluation of polymorphism at Cod on 192 of Paraoxonase 1 on its kinetic behavior

  2009cites this paper
• Protective effect of paraoxonase 1 of high‐density lipoprotein in type 2 diabetic patients with nephropathy

  2009cites this paper
• The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment.

  2009cites this paper
• Association between PON1 5'-regulatory region polymorphisms, PON1 activity and ischemic stroke.

  2009cites this paper
• Linkage analysis of albuminuria.

  2009cites this paper
• Complications of type 1 diabetes: new molecular findings.

  2008cites this paper
• Genetic epidemiology of diabetic retinopathy

  2008cites this paper
• Association Between p.Leu54Met Polymorphism at the Paraoxonase-1 Gene and Plantar Fascia Thickness in Young Subjects With Type 1 Diabetes

  2008influential citation
• Evaluation of Nε-(3-formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy

  2008influential citation
• Evaluation of paraoxonase activity in patients with mixed connective tissue disease.

  2008cites this paper
• Influência do exercício físico nas lipoproteínas e no endotélio de pacientes com síndrome metabólica

  2007cites this paper
• Reduced Paraoxonase1 Activity Is a Risk for Atherosclerosis in Patients with Systemic Lupus Erythematosus

  2007cites this paper
• Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans.

  2007cites this paper
• Candidate Genes for Late Diabetic Complications

  2007cites this paper
• Bibliography. Current world literature. Diabetes and the endocrine pancreas.

  2007cites this paper